Is methemoglobin an inert bystander, biomarker or a mediator of oxidative stress-the example of anemia?

Redox Biology

Volumn 1, Issue 1, 2013, Pages 65-69

  Hare, Gregory M T ^a,b   Tsuia, Albert K Y ^a   Crawford, Jack H ^c   Patel, Rakesh P ^d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

Anemia; Methemoglobin; Nitrite reductase

Indexed keywords

BIOLOGICAL MARKER; CYTOCHROME B5 REDUCTASE; DEOXYHEMOGLOBIN; METHEMOGLOBIN; NITRITE REDUCTASE; HEMOGLOBIN; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OXYGEN;

ANEMIA; ARTICLE; BYSTANDER EFFECT; DISEASE SEVERITY; ENZYME ACTIVITY; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPOXIA; MICROCIRCULATION; MORTALITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN SUPPLY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE BLOOD FLOW; VASCULAR SMOOTH MUSCLE; ACUTE DISEASE; BLEEDING; BLOOD TRANSFUSION; CELL AGING; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ERYTHROCYTE; FLUID RESUSCITATION; HEMOGLOBIN OXIDATION; HEMOGLOBIN SYNTHESIS; HYPOXEMIA; METHEMOGLOBIN BLOOD LEVEL; MORBIDITY; PATHOPHYSIOLOGY; PROTEIN METABOLISM; REVIEW; RISK REDUCTION; ANIMAL; METABOLISM;

ANIMALIA;

ACUTE DISEASE; ANEMIA; ANIMALS; BIOLOGICAL MARKERS; HUMANS; METHEMOGLOBIN; OXIDATIVE STRESS;

EID: 84878847533     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2012.12.003     Document Type: Review

References (33)

1. R. Ash-Bernal, R. Wise, S.M. Wright, Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals, Medicine (Baltimore) 83 (2004) 265-273.
2. G.M. Hare, A. Mu, A. Romaschin, et al., Plasma methemoglobin as a potential biomarker of anemic stress in humans, Canadian Journal of Anaesthesia 59 (2012) 348-356.
3. A.K. Tsui, N.D. Dattani, P.A. Marsden, et al., Reassessing the risk of hemodilu-tional anemia: some new pieces to an old puzzle, Canadian Journal of Anaesthesia 57 (2010) 779-791.
4. A. Shander, M. Javidroozi, S. Ozawa, G.M. Hare, What is really dangerous: anaemia or transfusion? British Journal of Anaesthesia 107 (1) (2011) i41-i59.
5. J.L. Carson, A. Duff, R.M. Poses, et al., Effect of anaemia and cardiovascular disease on surgical mortality and morbidity, Lancet 348 (1996) 1055-1060.
6. J.L. Carson, M.L. Terrin, H. Noveck, et al., Liberal or restrictive transfusion in high-risk patients after hip surgery, New England Journal of Medicine 365 (2011) 2453-2462.
7. J.L. Carson, P.A. Carless, P.C. Hebert, Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion, Cochrane Data-base of Systematic Reviews 4 (2012) CD002042.
8. L.A. Hajjar, J.L. Vincent, F.R. Galas, et al., Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial, Journal of the American Medical Association 304 (2010) 1559-1567.
9. P.C. Hebert, G. Wells, M.A. Blajchman, et al., A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfu-sion requirements in critical care investigators, Canadian critical care trials group, New England Journal of Medicine 340 (1999) 409-417.
10. J. Lacroix, P.C. Hebert, J.S. Hutchison, et al., Transfusion strategies for patients in pediatric intensive care units, New England Journal of Medicine 356 (2007) 1609-1619.
11. D. Wang, J. Sun, S.B. Solomon, H.G. Klein, C. Natanson, Transfusion of older stored blood and risk of death: a meta-analysis, Transfusion 52 (2012) 1184-1195.
12. G.M. Hare, C.D. Mazer, W. Mak, et al., Hemodilutional anemia is associated with increased cerebral neuronal nitric oxide synthase gene expression, Journal of Applied Physiology 94 (2003) 2058-2067.
13. A.T. McLaren, P.A. Marsden, C.D. Mazer, et al., Increased expression of HIF-1{alpha}, nNOS, and VEGF in the cerebral cortex of anemic rats, American Journal of Physiology Regulatory, Integrative and Comparative Physiology 292 (2007) R403-R414.
14. A.K. Tsui, P.A. Marsden, C.D. Mazer, et al., Priming of hypoxia-inducible factor by neuronal nitric oxide synthase is essential for adaptive responses to severe anemia, Proceedings of the National Academy of Sciences of the United States of America 108 (2011) 17544-17549.
15. J. van Bommel, A. Trouwborst, L. Schwarte, M. Siegemund, C. Ince, C. Henny, Intestinal and cerebral oxygenation during severe isovolemic hemodilution and subsequent hyperoxic ventilation in a pig model, Anesthesiology 97 (2002) 660-670.
16. R.N. Sladen, The oxyhemoglobin dissociation curve, International Anesthe-siology Clinics 19 (1981) 39-70.
17. T. Rodman, H.P. Close, M.K. Purcell, The oxyhemoglobin dissociation curve in anemia, Annals of Internal Medicine 52 (295-309) (1960) 295-309.
18. G.M. Hare, A.K. Tsui, A.T. McLaren, T.E. Ragoonanan, J. Yu, C.D. Mazer, Anemia and cerebral outcomes: many questions, fewer answers, Anesthesia and Analgesia 107 (2008) 1356-1370.
19. D.F. Wilson, D.K. Harrison, S.A. Vinogradov, Oxygen, pH, and mitochondrial oxidative phosphorylation, Journal of Applied Physiology 113 (12) (2012) 1838-1845.
20. Y. Huang, L. Lei, D. Liu, et al., Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1alpha-dependent function, Pro-ceedings of the National Academy of Sciences of the United States of America 109 (2012) 17478-17483.
21. G.L. Semenza, New insights into nNOS regulation of vascular homeostasis, Journal of Clinical Investigation 115 (2005) 2976-2978.
22. R.P. Patel, N. Hogg, D.B. Kim-Shapiro, The potential role of the red blood cell in nitrite-dependent regulation of blood flow, Cardiovascular Research 89 (2011) 507-515.
23. A.I. Alayash, R.P. Patel, R.E. Cashon, Redox reactions of hemoglobin and myoglobin: biological and toxicological implications, Antioxidants and Redox Signaling 3 (2001) 313-327.
24. D.J. Singel, J.S. Stamler, Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin, Annual Review of Physiology 67 (99-145) (2005) 99-145.
25. M.T. Gladwin, N.J. Raat, S. Shiva, et al., Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation, American Journal of Physiology Heart and Circulatory Physiol-ogy 291 (2006) H2026-H2035.
26. A.C. Straub, A.W. Lohman, M. Billaud, Endothelial cell expression of haemo-globin alpha regulates nitric oxide signalling, Nature 491 (2012) 473-477.
27. P.W. Buehler, F. D'Agnillo, D.J. Schaer, Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design, Trends in Molecular Medicine 16 (2010) 447-457.
28. B.Y. Owusu, R. Stapley, R.P. Patel, Nitric oxide formation versus scavenging: the red blood cell balancing act, Journal of Physiology 590 (2012) 4993-5000.
29. S. Basu, R. Grubina, J. Huang, et al., Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobin, Nature Chemical Biology 3 (2007) 785-794.
30. J.H. Crawford, T.S. Isbell, Z. Huang, et al., Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation, Blood 107 (2006) 566-574.
31. C. Donadee, N.J. Raat, T. Kanias, et al., Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion, Circulation 124 (2011) 465-476.
32. R. Stapley, B.Y. Owusu, A. Brandon, et al., Erythrocyte storage increases rates of NO and nitrite scavenging: implications for transfusion-related toxicity, Biochemical Journal 446 (2012) 499-508.
33. C. Natanson, S.J. Kern, P. Lurie, S.M. Banks, S.M. Wolfe, Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis, Journal of the American Medical Association 299 (2008) 2304-2312.